← Leaderboards
Michael S Binkley
Stanford University
$569,568
Attributed
$569,568
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $284.8K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$569,568 · 1
By mechanism
K08$569,568 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Sylvia Katina Plevritis$44,733,712
- Hanlee Ji$24,780,644
- Ronald Levy$27,846,042
- Linda M Boxer$7,394,229
- Joseph C Wu$80,370,369
Others in their field
Other Rising Stars on “Aftercare”
- Xuping Xie · University Of Texas Med Br Galveston$10,877,958
- Michael E. Roth · Public Health Institute$8,303,012
- Leonard R. Henry · Northside Hospital Atlanta$4,036,775
- Salwa A Elgebaly · Nour Heart, Inc.$3,582,845
- Cindy S Chu · University Of Oxford$3,470,639
- Emil Schueler · University Of Tx Md Anderson Can Ctr$3,375,134
Research focus
AftercareB-Cell LymphomasBioinformaticsBiomarker IdentificationBiometryBiopsyBlood SpecimenCancer BiologyCardiotoxicityCardiovascular DiseasesCardiovascular Disorder RiskCardiovascular Risk FactorCareerCareer DevelopmentCellsCell TransformationCell TypeCessation Of LifeChemotherapyChemotherapy And/Or RadiationClinically ActionableClinical ProtocolsClinical TrialsActive Method
Grant awards (2)
Investigating personalized approaches to de-intensify therapy for nodular lymphocyte-predominant Hodgkin lymphoma$284,784
K08 · FY2025 · CA · contact PI
Investigating personalized approaches to de-intensify therapy for nodular lymphocyte-predominant Hodgkin lymphoma$284,784
K08 · FY2024 · CA · contact PI